Advestra and Gütt Olk Feldhaus advised LOGEX on the acquisition of INMED advised by HEUKING . LOGEX Healthcare Analytics acquires INMED (Angewandte Informatik für medizinisches Controlling...
LOGEX Healthcare Analytics’ Acquisition Of INMED
ProductLife Group’s Acquisition Of IntiQuan AG
Advestra advised the sellers on the sale. ProductLife Group (PLG), a global provider of regulatory, scientific, compliance, and digital transformation consulting services for the life sciences...
Cactus Life Sciences’ Acquisition Of nspm And eluSCIdate
Advestra acted as legal counsel to Cactus Life Sciences in this transaction. Cactus Life Sciences, a leading global scientific communications agency that works with blue chip...
Addex Therapeutics Ltd’s Launch of Neurosterix
Homburger advised Addex Therapeutics Ltd., Advestra acted for Perceptive Advisors. Addex Therapeutics, a clinical-stage biopharmaceutical company, listed on the SIX Swiss Exchange and on the Nasdaq,...
RMB Group’s Strategic Partnership With eevolve
Advestra advised RMB Group on the deal. RMB Group, a leading Swiss planning and consulting company focused on building, energy and environmental technology and eevolve, a...
Marc O’Polo’s Acquisition of Swiss Business From Bollag-Guggenheim
Advestra advises Marc O’Polo on the acquisition. Marc O’Polo Group has agreed to acquire the Swiss business, consisting of the retail stores and the wholesale business,...
Ironwood Pharmaceuticals’ $1 Billion Acquisition of VectivBio Holding
Advestra and Latham & Watkins advise Ironwood. Homburger AG serves as legal and tax advisor to VectivBio on the transaction. Goodwin advises Centerview Partners. VectivBio Holding...
Belden’s Acquisition of NetModule Group
McDermott Will & Emery and Loyens & Loeff advised Belden on the deal. Belden Inc. announced its full acquisition of NetModule Group. As a result of...
Doetsch Grethes Acquisition of Kalium Hausmann Effervetten and Kalium Hausmann KCL-retard
Loyens & Loeff advised and acted as legal counsel to Vifor Pharma on the deal. Vifor Pharma completed the sale of two potassium-containing, prescription medicinal products...